← Open Payments lookup

DANIEL COX: Open Payments

NPI 1376056234 · LONGVIEW, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,128 in 95 payments from 21 companies in 2025. Trend: 2023 $2,916 · 2024 $2,515 · 2025 $2,128

Food & beverage: $2,128
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.24$459
Janssen Biotech, Inc.5$210
ABBVIE INC.12$206
Antares Pharma, Inc.8$165
Boston Scientific Corporation2$159
Olympus America Inc.8$150
Verity Pharmaceuticals Inc.5$121
Endo USA, Inc.5$112
PROGENICS PHARMACEUTICALS, INC.4$97
Teleflex LLC3$68

Products named: GEMTESA, XYOSTED, iTIND System, BOTOX, Axonics, RYBREVANT, PYLARIFY, ERLEADA.

Industry payments across WA — which companies pay providers there.